Towards nanomedicines for neuroAIDS

Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers

(2013) Madhavan Nair et al.   Nature Communications

Magnetic nanoparticles for the manipulation of proteins and cells

(2012) Yue Pan et al.   CHEMICAL SOCIETY REVIEWS

Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis

(2012) L. B. Jaeger et al.   Disease Models & Mechanisms

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells

(2012) Georgette Kanmogne et al.   International Journal of Nanomedicine

Nanoparticle Based Galectin-1 Gene Silencing, Implications in Methamphetamine Regulation of HIV-1 Infection in Monocyte Derived Macrophages

(2012) Jessica L. Reynolds et al.   Journal of Neuroimmune Pharmacology

Neuroimaging studies of the aging HIV-1-infected brain

(2012) John L. Holt et al.   JOURNAL OF NEUROVIROLOGY

Nonhuman Primate Models for HIV Cure Research

(2012) Cristian Apetrei et al.   PLoS Pathogens

Nanotechnological advances for the delivery of CNS therapeutics

(2011) Ho Lun Wong et al.   ADVANCED DRUG DELIVERY REVIEWS

Cell-mediated drug delivery

(2011) Elena V Batrakova et al.   Expert Opinion on Drug Delivery

Impact of current antiretroviral therapies on neuroAIDS

(2011) Pornpun Vivithanaporn et al.   Expert Review of Anti-Infective Therapy

Bacterial Magnetosome: A Novel Biogenetic Magnetic Targeted Drug Carrier with Potential Multifunctions

(2011) Jianbo Sun et al.   Journal of Nanomaterials

In Vitro Blood–Brain Barrier Models: Current and Perspective Technologies

(2011) Pooja Naik et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Carbosilane Dendrimers to Transfect Human Astrocytes with Small Interfering RNA Targeting Human Immunodeficiency Virus

(2010) Jose Luis Jiménez et al.   BIODRUGS

Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice

(2010) C. J. Destache et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Immunology as it Pertains to Drugs of Abuse, AIDS and the Neuroimmune Axis: Mediators and Traffic

(2010) Thomas J. Rogers   Journal of Neuroimmune Pharmacology

Nanoformulated Antiretroviral Drug Combinations Extend Drug Release and Antiretroviral Responses in HIV-1-Infected Macrophages: Implications for NeuroAIDS Therapeutics

(2010) Ari S. Nowacek et al.   Journal of Neuroimmune Pharmacology

Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson’s disease

(2010) Anna M Brynskikh et al.   Nanomedicine

Nanomicellar formulations for sustained drug delivery: strategies and underlying principles

(2010) Ruchit Trivedi et al.   Nanomedicine

Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs

(2009) Simi Gunaseelan et al.   ADVANCED DRUG DELIVERY REVIEWS

Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting

(2009) Umesh Gupta et al.   ADVANCED DRUG DELIVERY REVIEWS

Nanotechnology applications for improved delivery of antiretroviral drugs to the brain

(2009) Ho Lun Wong et al.   ADVANCED DRUG DELIVERY REVIEWS

Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs

(2009) Puneet Sharma et al.   ADVANCED DRUG DELIVERY REVIEWS

The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further research

(2009) Lavanya Varatharajan et al.   ANTIVIRAL RESEARCH

MMP-9 gene silencing by a quantum dot–siRNA nanoplex delivery to maintain the integrity of the blood brain barrier

(2009) Adela Bonoiu et al.   BRAIN RESEARCH

Drug-resistant human immunodefiency virus

(2009) M.J. Kozal   CLINICAL MICROBIOLOGY AND INFECTION

Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses

(2009) Abeer M. Al-Ghananeem et al.   JOURNAL OF DRUG TARGETING

Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS

(2009) H. Dou et al.   JOURNAL OF IMMUNOLOGY

AZT 5′-triphosphate nanoformulation suppresses human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells

(2009) Zainulabedin M Saiyed et al.   JOURNAL OF NEUROVIROLOGY

Neurologic Presentations of AIDS

(2009) Elyse J. Singer et al.   NEUROLOGIC CLINICS

Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders

(2009) Steven Paul Woods et al.   NEUROPSYCHOLOGY REVIEW

TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs

(2008) Kavitha S. Rao et al.   BIOMATERIALS

Cellular Reservoirs of HIV-1 and their Role in Viral Persistence

(2008) Aikaterini Alexaki et al.   CURRENT HIV RESEARCH

Regulation of ABC membrane transporters in glial cells: Relevance to the pharmacotherapy of brain HIV-1 infection

(2008) Patrick T. Ronaldson et al.   GLIA

Nonhuman primate models of NeuroAIDS

(2008) Rachel Williams et al.   JOURNAL OF NEUROVIROLOGY

Biodistribution, Clearance, and Biocompatibility of Iron Oxide Magnetic Nanoparticles in Rats

(2008) Tapan K. Jain et al.   MOLECULAR PHARMACEUTICS

Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: Current status of dopamine system vulnerability in NeuroAIDS

(2008) Mark J. Ferris et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Solid Lipid Nanoparticles Enhance the Delivery of the HIV Protease Inhibitor, Atazanavir, by a Human Brain Endothelial Cell Line

(2008) Niladri Chattopadhyay et al.   PHARMACEUTICAL RESEARCH

Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations

(2007) Tushar K. Vyas et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Electromagnetic interference in the permeability of saquinavir across the blood–brain barrier using nanoparticulate carriers

(2007) Y KUO et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS